Amyloid beta oligomers induce impairment of neuronal insulin receptors

Zhao, Wei‐Qin, De Felice, Fernanda G., Fernandez, Sara, Chen, Hui, Lambert, Mary P., Quon, Michael J., Krafft, Grant A., Klein, William L.·2008·The FASEB Journal

DOI 10.1096/fj.06-7703com

Cited by (590)

Items 101–200 of 590

Why is the amyloid beta peptide of Alzheimer’s disease neurotoxic?
Rauk, Arvi · 2008 · Dalton Transactions
Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloidpeptide, insulin signaling, and neuronal function
Shuko Takeda, Naoyuki Sato, Hiromi Rakugi, Ryuichi Morishita · 2011 · Molecular BioSystems
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
Marcelo N. N. Vieira, Ricardo A. S. Lima‐Filho, Fernanda G. De Felice · 2017 · Neuropharmacology
Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model
Liqin Qi, Linfang Ke, Xiaohong Liu, Lianming Liao, Sujie Ke, Xiaoying Liu, Yanping Wang, Xiaowei Lin, Yu Zhou, Lijuan Wu et al. · 2016 · European Journal of Pharmacology
The incretin hormones glucagonlike peptide 1 and glucose‐dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease
Christian Hölscher · 2014 · Alzheimer s & Dementia
Interactions Between Age, Stress and Insulin on Cognition: Implications for Alzheimer's Disease
Solas, Maite, Aisa, Bárbara, Mugueta, María C, Del Río, Joaquín, Tordera, Rosa M, Ramírez, María J · 2010 · Neuropsychopharmacology
Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
Barini, Erica, Antico, Odetta, Zhao, Yingjun, Asta, Francesco, Tucci, Valter, Catelani, Tiziano, Marotta, Roberto, Xu, Huaxi, Gasparini, Laura · 2016 · Molecular Neurodegeneration
Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer’s Disease: Impacts on Cognitive Decline
Jennifer Walker, Fiona Edith Harrison · 2015 · Nutrients
Insulin resistance in Alzheimer's disease
Kelly T. Dineley, Jordan B. Jahrling, Larry A. Denner · 2014 · Neurobiology of Disease
Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
Marcelo N. N. Vieira, Natalia M. Lyra e Silva, Sergio Teixeira Ferreira, Fernanda G. De Felice · 2017 · Frontiers in Aging Neuroscience
The dendritic hypothesis for Alzheimer's disease pathophysiology
Cochran, J. Nicholas, Hall, Alicia M., Roberson, Erik D. · 2014 · Brain Research Bulletin
Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer‘s Disease
Nuzzo, Domenico, Picone, Pasquale, Baldassano, Sara, Caruana, Luca, Messina, Elisa, Gammazza, Antonella, Cappello, Francesco, Mulè, Flavia, Carlo, Marta · 2015 · Current Alzheimer Research
Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer's disease
Pasquale Picone, Lorena Anna Ditta, Maria Antonietta Sabatino, Valeria Militello, Pier Luigi San Biagio, Maria Laura Di Giacinto, Laura Cristaldi, Domenico Nuzzo, Clelia Dispenza, Daniela Giacomazza et al. · 2015 · Biomaterials
Amyloid-beta and tau protein beyond Alzheimer’s disease
Morteza Abyadeh, Vivek Gupta, João A. Paulo, Arezoo Gohari Mahmoudabad, Sina Shadfar, Shahab Mirshahvaladi, Veer Bala Gupta, Christine T. O. Nguyen, David Isaac Finkelstein, Yuyi You et al. · 2023 · Neural Regeneration Research
Hyperphosphorylation of Tau Induced by Naturally Secreted Amyloid-β at Nanomolar Concentrations Is Modulated by Insulin-dependent Akt-GSK3β Signaling Pathway
Takayoshi Tokutake, Kensaku Kasuga, Ryuji Yajima, Yumi Sekine, Toshiyuki Tezuka, Masatoyo Nishizawa, Takeshi Ikeuchi · 2012 · Journal of Biological Chemistry
Insulin resistance in Alzheimer's disease
Thomas C. Diehl, Roger J. Mullins, Dimitrios Kapogiannis · 2016 · Translational research
Amyloid‐β and islet amyloid pathologies link Alzheimer’s disease and type 2 diabetes in a transgenic model
Nadeeja Wijesekara, Rosemary Ahrens, Miheer Sabale, Ling Wu, Kathy Ha, Giuseppe Verdile, Paul E. Fraser · 2017 · The FASEB Journal
Cellular prion protein is essential for oligomeric amyloid- -induced neuronal cell death
Wataru Kudo, Lee Hp, W.-Q. Zou, X. Wang, G. Perry, X. Zhu, M. A. Smith, Robert B. Petersen, Hyoung‐gon Lee · 2011 · Human Molecular Genetics
Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis
Botond Penke, Mária Szűcs, Ferenc Bogár · 2020 · Molecules
APP Receptor? To Be or Not To Be
Carole Deyts, Gopal Thinakaran, Angèle Parent · 2016 · Trends in Pharmacological Sciences
Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APP swe/ PS 1dE9 mice
Yanfang Mao, Zhangyu Guo, Tingting Zheng, Yasi Jiang, Yaping Yan, Xinzhen Yin, Yanxing Chen, Baorong Zhang · 2016 · Aging Cell
ADDLs and the signaling web that leads to Alzheimer’s disease
Grant A. Krafft, William L. Klein · 2010 · Neuropharmacology
The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease
Wang, Zi-Xuan, Tan, Lan, Liu, Jinyuan, Yu, Jin-Tai · 2016 · Molecular Neurobiology
The relationship between type 2 diabetes and dementia
Mark W. J. Strachan, Rebecca M. Reynolds, B M Frier, R. J. Mitchell, Jackie F. Price · 2008 · British Medical Bulletin
The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer’s disease
A. M. Duffy, Christian Hölscher · 2012 · Neuroscience
The complex relationship between obesity and neurodegenerative diseases: an updated review
Alexandre Neto, Adelaide Maria Afonso Fernandes, Andreia Pereira Barateiro · 2023 · Frontiers in Cellular Neuroscience
Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity
Fuxiang Bao, Linn Wicklund, Pascale N. Lacor, William L. Klein, Agneta K. Nordberg, Amelia Marutle · 2011 · Neurobiology of Aging
Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity
Levi M. Smith, Stephen M. Strittmatter · 2016 · Cold Spring Harbor Perspectives in Medicine
Diabetes as a risk factor for Alzheimer’s disease in the Middle East and its shared pathological mediators
Richard L. Jayaraj, Sheikh Azimullah, Rami Beiram · 2019 · Saudi Journal of Biological Sciences
Nutrition and Alzheimer's disease: The detrimental role of a high carbohydrate diet
Stephanie Seneff, Glyn Wainwright, Luca Mascitelli · 2011 · European Journal of Internal Medicine
Low Density Lipoprotein Receptor-related Protein 1 Promotes Anti-apoptotic Signaling in Neurons by Activating Akt Survival Pathway
Rodrigo A. Fuentealba, Qiang Liu, Takahisa Kanekiyo, Juan Zhang, Guojun Bu · 2009 · Journal of Biological Chemistry
Alzheimer’s Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies
Jonathan Chang-Cheng Shieh, Pai-Tsang Huang, Yung‐Feng Lin · 2020 · Molecular Neurobiology
Vascular and metabolic dysfunction in Alzheimer’s disease: a review
Murray, Ian V J, Proza, Joseph F, Sohrabji, Farida, Lawler, John M · 2011 · Experimental Biology and Medicine
Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides
Angela J. Hanson, Jennifer L. Bayer-Carter, Pattie S. Green, Thomas Jude Montine, Charles W. Wilkinson, Laura D. Baker, G. Stennis Watson, Laura M. Bonner, Maureen Callaghan, James B. Leverenz et al. · 2013 · JAMA Neurology
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Takashi Amemori, Pavla Jendelová, Jiří Růžička, Lucia Machová Urdzíková, Eva Syková · 2015 · International Journal of Molecular Sciences
Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers Disease
Holscher, Christian · 2010 · Recent Patents on CNS Drug Discovery
Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models
Sayuri Higaki, Masashi Muramatsu, Akio Matsuda, Kenji Matsumoto, Jun‐ichi Satoh, Makoto Michikawa, Shumpei Niida · 2018 · PLoS ONE
Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration
Caio Henrique Mazucanti, João Victor Cabral‐Costa, Andréa Rodrigues Vasconcelos, Diana Zukas Andreotti, Cristóforo Scavone, Elisa Mitiko Kawamoto · 2015 · Current Topics in Medicinal Chemistry
Differential metformin dose-dependent effects on cognition in rats: role of Akt
Dalia Kamal Mostafa, Cherine Adel Ismail, Doaa Ahmad Ghareeb · 2016 · Psychopharmacology
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
Mara Dierssen, Marta Fructuoso, María Martínez de Lagrán, Marzia Perluigi A, Eugenio Barone · 2020 · Frontiers in Neuroscience
The effects of cardiovascular risk factors on cognitive compromise
Michal Schnaider Beeri, Ramit Ravona‐Springer, Jeremy M. Silverman, Vahram H. Haroutunian · 2009 · Dialogues in Clinical Neuroscience
Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis
Athanasia Athanasaki, Konstantinos Melanis, Ioanna Tsantzali, Maria‐Ioanna Stefanou, Sofia Ntymenou, Sotirios G. Paraskevas, Theodosis Κalamatianos, Eleni I. Boutati, Vaia Lambadiari, Konstantinos I. Voumvourakis et al. · 2022 · Biomedicines
Why Alzheimer's is a disease of memory: The attack on synapses by Aß oligomers (ADDLs)
Kirsten L. Viola, Pauline T. Velasco, W L Klein · 2008 · The journal of nutrition health & aging
Estrogen Regulation of Mitochondrial Bioenergetics
Jia Yao, Roberta Dı́az Brinton · 2012 · Advances in pharmacology
GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes
Marine Monney, François R. Jornayvaz, Karim Gariani · 2023 · Diabetes & Metabolism
New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer’s disease?
Christian Hölscher, Lin Li · 2008 · Neurobiology of Aging
Amyloid-β Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway
Yi Zhang, Ben Zhi Zhou, Fang Zhang, Jingxia Wu, Yanan Hu, Yang Liu, Qiwei Zhai · 2012 · Diabetes
Microglia and the Blood–Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions
Giorgia Serena Gullotta, Giuseppe Costantino, Maria Angela Sortino, Simona Federica Spampinato · 2023 · International Journal of Molecular Sciences
Increased Food Intake Leads to Obesity and Insulin Resistance in the Tg2576 Alzheimer’s Disease Mouse Model
Motoyuki Kohjima, Yuxiang Sun, Lawrence Chan · 2010 · Endocrinology
Chenodeoxycholic Acid Ameliorates AlCl3-Induced Alzheimer’s Disease Neurotoxicity and Cognitive Deterioration via Enhanced Insulin Signaling in Rats
Bazzari, Firas H., Abdallah, Dalaal M., El-Abhar, Hanan S. · 2019 · Molecules
The Monomer State of Beta-Amyloid: Where the Alzheimer's Disease Protein Meets Physiology
Maria Laura Giuffrida, Filippo Caraci, Paolo De Bona, G. Pappalardo, Ferdinando Nicoletti, Enrico Rizzarelli, Agata Copani · 2010 · Reviews in the Neurosciences
Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats
Qingjie Chen, Ran Mo, Ning‐hua Wu, Xin Zou, Cai Shi, Jing Gong, Jingbin Li, Ke Fang, Dingkun Wang, Yang De-shen et al. · 2017 · Frontiers in Pharmacology
Protease-Resistant Glucose-Dependent Insulinotropic Polypeptide Agonists Facilitate Hippocampal LTP and Reverse the Impairment of LTP Induced by Beta-Amyloid
Victor A. Gault, Christian Hölscher · 2008 · Journal of Neurophysiology
Increased Aβ production prompts the onset of glucose intolerance and insulin resistance
Margarita Jiménez-Palomares, Juan José Ramos‐Rodríguez, José Francisco López-Acosta, Mar Pacheco‐Herrero, Alfonso Maria Lechuga-Sancho, Germán Perdomo, Mónica Garcı́a-Alloza, Irene Cózar‐Castellano · 2012 · American Journal of Physiology-Endocrinology and Metabolism
Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging
Shaniya Maimaiti, Katie L. Anderson, Chris DeMoll, Lawrence D. Brewer, Benjamin A. Rauh, John C. Gant, Eric M. Blalock, Nada M. Porter, Olivier Thibault · 2015 · The Journals of Gerontology Series A
X-ray Crystallographic Structures of Trimers and Higher-Order Oligomeric Assemblies of a Peptide Derived from Aβ17–36
Ryan K. Spencer, Hao Li, James S. Nowick · 2014 · Journal of the American Chemical Society
Pathogenesis of Abeta Oligomers in Synaptic Failure
Senthilkumar Sivanesan, Aaron Tan, Jayakumar Rajadas · 2013 · Current Alzheimer Research
Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways
Marzia Perluigi A, Eugenio Barone, Fabio Di Domenico, David Allan Butterfield · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Amyloid-β Oligomers Induce Differential Gene Expression in Adult Human Brain Slices
Adriano Silva Sebollela, Léo Freitas-Corrêa, Fabio Ferreira de Oliveira, Andrea Cristina Paula-Lima, Leonardo Martins Saraiva, Samantha M. Martins, Louise D. C. Mota, César Torres, Soniza Vieira Alves‐Leon, Jorge Marcondes de Souza et al. · 2012 · Journal of Biological Chemistry
Neuroprotective astrocyte-derived insulin/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound Aβ oligomers
Jason E. Pitt, Kyle C. Wilcox, Vanessa Tortelli, Luan Pereira Diniz, Maira S. Oliveira, Cassandra Dobbins, Xiaowen Yu, Sathwik Nandamuri, Flávia Carvalho Alcântara Gomes, Nadia DiNunno et al. · 2017 · Molecular Biology of the Cell
Prion Protein as a Toxic Acceptor of Amyloid-β Oligomers
Silvia A. Purro, Andrew J. Nicoll, John Collinge · 2017 · Biological Psychiatry
Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice
Ángel Trueba-Sáiz, Carmen Cavada, Ana Maria Fernandez, T Leon, D A González, Juan Fortea, Alberto Lleó, Teodoro del Ser, Ángel Núñez, Ignacio Torres‐Alemán · 2013 · Translational Psychiatry
Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
Émilie Faivre, Christian Hölscher · 2013 · Alzheimer s Research & Therapy
Deregulation of brain insulin signaling in Alzheimer’s disease
Yanxing Chen, Yanqiu Deng, Baorong Zhang, Cheng‐Xin Gong · 2014 · Neuroscience Bulletin
Alzheimer's Disease and Diabetes: An Integrative View of the Role of Mitochondria, Oxidative Stress, and Insulin
Paula Isabel Moreira · 2012 · Journal of Alzheimer s Disease
Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition
Paul Denver, Paula L. McClean · 2018 · Neural Regeneration Research
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Waqar Ahmad · 2012 · Molecular Neurobiology
Amyloid-β Induces Hepatic Insulin Resistance In Vivo via JAK2
Yi Zhang, Ben Zhi Zhou, Bo Deng, Fang Zhang, Jingxia Wu, Yuangao Wang, Yingying Le, Qiwei Zhai · 2012 · Diabetes
Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression
Cristy Phillips, Atoossa Fahimi · 2018 · Frontiers in Neuroscience
RETRACTED: Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease
Leela Paladugu, Abeer Gharaibeh, Nivya Kolli, Cameron R. Learman, Tia C. Hall, Lixin Li, Julien Rossignol, Panchanan Maiti, Gary Leo Dunbar · 2021 · International Journal of Molecular Sciences · Retracted
Impaired peripheral glucose homeostasis and Alzheimer's disease
Nadeeja Wijesekara, Rafaella Araujo Gonçalves, Fernanda G. De Felice, Paul E. Fraser · 2017 · Neuropharmacology
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
Xiangyuan Meng, Qi Song, Zinan Liu, Xinpeng Liu, Yujie Wang, Jinyu Liu · 2024 · Frontiers in Aging Neuroscience
Amyloid-β and Tau Pathology of Alzheimer's Disease Induced by Diabetes in a Rabbit Animal Model
Claudine L. Bitel, Chinnaswamy Kasinathan, Rajesh H. Kaswala, William L. Klein, Peter H. Frederikse · 2012 · Journal of Alzheimer s Disease
Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?
Yun Zhang, Weihong Song · 2017 · Progress in Neurobiology
Obesity and Alzheimer’s disease: Molecular bases
Pasquale Picone, Marta Di Carlo, Domenico Nuzzo · 2020 · European Journal of Neuroscience
Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases
André F. Batista, Victor Bodart‐Santos, Fernanda G. De Felice, Sergio Teixeira Ferreira · 2018 · CNS Drugs
Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Maria Assunta Potenza, Luca Sgarra, Vanessa Desantis, Carmela Nacci, Monica Montagnani · 2021 · Antioxidants
The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player
Yasmin Amy Divecha, Sanketh Rampes, Sabine Tromp, Sevda Boyanova, Alice L. Fleckney, Mehmet Fidanboylu, Sarah Ann Thomas · 2025 · Pharmacological Reviews
Do Astrocytes Collaborate with Neurons in Spreading the “Infectious” Aβ and Tau Drivers of Alzheimer’s Disease?
Ilaria Dal Prà, Anna Chiarini, Li Gui, Balu Chakravarthy, Raffaella Pacchiana, Emanuela Gardenal, James F. Whitfield, Ubaldo Armato · 2014 · The Neuroscientist
The Role of GLP-1 in Neuronal Activity and Neurodegeneration
Hölscher, Christian · 2010 · Vitamins & Hormones
Amyloid-beta oligomers increase the localization of prion protein at the cell surface: PrPC trafficking and Alzheimer’s disease
Caetano, Fabiana A., Beraldo, Flavio H., Hajj, Glaucia N. M., Guimaraes, Andre L., Jürgensen, Sofia, Wasilewska-Sampaio, Ana Paula, Hirata, Pedro H. F., Souza, Ivana, Machado, Cleiton F., Wong, Daisy Y.-L. et al. · 2011 · Journal of Neurochemistry
Insulin resistance, neuroinflammation, and Alzheimer’s disease
Dema Najem, Michelle Bamji‐Mirza, Nina Chang, Qing Yan Liu, Wandong Zhang · 2014 · Reviews in the Neurosciences
A Common Pathogenic Mechanism Linking Type-2 Diabetes and Alzheimer's Disease: Evidence from Animal Models
Sun Ah Park · 2011 · Journal of Clinical Neurology
Insulin and Its Key Role for Mitochondrial Function/Dysfunction and Quality Control: A Shared Link between Dysmetabolism and Neurodegeneration
Giacoma Galizzi, Marta Di Carlo · 2022 · Biology
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Tramutola, Antonella, Lanzillotta, Chiara, Di Domenico, Fabio, Head, Elizabeth, Butterfield, D. Allan, Perluigi, Marzia, Barone, Eugenio · 2020 · Neurobiology of Disease
The novel vaccine peptide GV1001 effectively blocks β-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase
Park, Hyun-Hee, Lee, Kyu-Yong, Kim, Sangjae, Lee, Jessica Woojin, Choi, Na-Young, Lee, Eun-Hye, Lee, Young Joo, Lee, Sang-Hun, Koh, Seong-Ho · 2014 · Neurobiology of Aging
Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
Jordi Olloquequi, Amanda C. Cano, Elena Sánchez‐López, Marina Carrasco, Ester Verdaguer, Ana C. Fortuna, Jaume Folch, Mònica Bulló, Carme Auladell, Antoni Camins et al. · 2022 · Biomedicine & Pharmacotherapy
Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes
Mychael V. Lourenco, Sergio Teixeira Ferreira, Fernanda G. De Felice · 2015 · Progress in Neurobiology
Peptide multifunctionalized gold nanorods decrease toxicity of β-amyloid peptide in a Caenorhabditis elegans model of Alzheimer's disease
Francisco Morales-Zavala, Héctor Arriagada, Natalia Hassan, Carolina Velasco, Ana Luisa Riveros, Alejandra R. Alvarez, Alicia N. Minniti, Ximena Rojas‐Silva, Luis L. Muñoz, Rodrigo A. Vásquez et al. · 2017 · Nanomedicine Nanotechnology Biology and Medicine
Insulin: An Emerging Treatment for Alzheimer’s Disease Dementia?
Jill K. Morris, Jeffrey Murray Burns · 2012 · Current Neurology and Neuroscience Reports
Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice
Francesca Masciopinto, Natalia Di Pietro, Carlo Corona, Manuela Bomba, Caterina Pipino, M Curcio, Augusto Filippo Di Castelnuovo, Domenico Ciavardelli, Elena Silvestri, Lorella M.T. Canzoniero et al. · 2012 · Cell Death and Disease
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
Sciaccaluga, Miriam, Megaro, Alfredo, Bellomo, Giovanni, Ruffolo, Gabriele, Romoli, Michele, Palma, Eleonora, Costa, Cinzia · 2021 · International Journal of Molecular Sciences
Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease
L.M. Vargas, Waldo F. Cerpa, Francisco J. Muñoz, Silvana Zanlungo, Alejandra R. Alvarez · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies.
Tramutola, Antonella, Lanzillotta, Chiara, Di Domenico, Fabio · 2017 · Expert Review of Neurotherapeutics
Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25–35 in human cortical astrocytes and neurons—Therapeutic relevance to Alzheimer's disease
Armato, Ubaldo, Chiarini, Anna, Chakravarthy, Balu, Chioffi, Franco, Pacchiana, Raffaella, Colarusso, Enzo, Whitfield, James F., Dal Prà, Ilaria · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Peptides as Potential Therapeutics for Alzheimer’s Disease
Samo Ribarič · 2018 · Molecules
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
Jaume Folch, Jordi Olloquequi, Miren Ettcheto, Oriol Busquets, Elena Sánchez‐López, Amanda C. Cano, Triana Espinosa-Jiménez, Maria Luisa García, Carlos Beas‐Zárate, Gemma Casadesús et al. · 2019 · Frontiers in Aging Neuroscience
Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
Sim, A Young, Barua, Sumit, Kim, Jong Youl, Lee, Yong-ho, Lee, Jong Eun · 2021 · Frontiers in Neuroscience
The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice
Molly Stanley, Shannon L. Macauley, Emily E. Caesar, Lauren J. Koscal, Will Moritz, Grace O. Robinson, Joseph Roh, Jennifer Keyser, Hong Jiang, David M. Holtzman · 2016 · Journal of Neuroscience
Broadening the definition of brain insulin resistance in aging and Alzheimer's disease
Hilaree N. Frazier, Adam O. Ghoweri, Katie L. Anderson, Ruei‐Lung Lin, Nada M. Porter, Olivier Thibault · 2018 · Experimental Neurology